Michael K. Schultz
Technik-/Wissenschafts-/F&E-Leiter bei PERSPECTIVE THERAPEUTICS, INC.
Profil
Michael K.
Schultz founded Viewpoint Molecular Targeting, Inc. in 2008, where he is working as Chief Science Officer from 2013.
Dr. Schultz also currently works at Perspective Therapeutics, Inc., as Chief Science Officer.
Dr. Schultz also formerly worked at the University of Iowa, as Associate Professor and National Institute of Health Policy, as Principal.
Aktive Positionen von Michael K. Schultz
| Unternehmen | Position | Beginn |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Gründer | 01.01.2008 |
Ehemalige bekannte Positionen von Michael K. Schultz
| Unternehmen | Position | Ende |
|---|---|---|
| National Institute of Health Policy | Corporate Officer/Principal | - |
| University of Iowa | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Commercial Services |
| National Institute of Health Policy |
